These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9062678

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Systemic administration of dynorphin A-(1-13) markedly improves cycloheximide-induced amnesia in mice.
    Ukai M, Shan-Wu X, Kobayashi T, Kameyama T.
    Eur J Pharmacol; 1996 Oct 10; 313(1-2):11-5. PubMed ID: 8905323
    [Abstract] [Full Text] [Related]

  • 4. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice.
    Itoh J, Ukai M, Kameyama T.
    Eur J Pharmacol; 1993 Jun 04; 236(3):341-5. PubMed ID: 8102969
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance.
    Itoh J, Ukai M, Kameyama T.
    Eur J Pharmacol; 1993 Sep 07; 241(1):99-104. PubMed ID: 7901037
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice.
    Hiramatsu M, Sasaki M, Nabeshima T, Kameyama T.
    Pharmacol Biochem Behav; 1997 Jan 07; 56(1):73-9. PubMed ID: 8981612
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
    Hiramatsu M, Inoue K.
    Br J Pharmacol; 1999 Jun 07; 127(3):655-60. PubMed ID: 10401555
    [Abstract] [Full Text] [Related]

  • 17. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist.
    Hiramatsu M, Murasawa H, Mori H, Kameyama T.
    Br J Pharmacol; 1998 Mar 07; 123(5):920-6. PubMed ID: 9535021
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesia in mice.
    Hiramatsu M, Inoue K, Kameyama T.
    Neuroreport; 2000 Feb 28; 11(3):431-5. PubMed ID: 10718289
    [Abstract] [Full Text] [Related]

  • 20. Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice.
    Sakaguchi M, Koseki M, Wakamatsu M, Matsumura E.
    Eur J Pharmacol; 2006 Jan 13; 530(1-2):81-7. PubMed ID: 16360145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.